Skip to main
HSIC
HSIC logo

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 25 analyst ratings
Hold
Strong Buy 16%
Buy 24%
Hold 52%
Sell 8%
Strong Sell 0%

Bulls say

Henry Schein Inc. demonstrated a positive growth trajectory, with dental business revenue increasing by 6.2% and adjusted EBITDA anticipated to grow by a mid-single-digit percentage, reflecting strong operational performance. The global technology segment also contributed positively with reported revenue of $160 million and a growth rate of 2.4%, indicating a robust demand for healthcare solutions. Furthermore, the company's outlook for non-GAAP EPS, projected between $4.80-4.94, combined with expectations for accelerated earnings growth post-2025, reinforces a favorable financial outlook.

Bears say

Henry Schein Inc. reported disappointing fourth-quarter results, with total revenue of $3.19 billion, representing a growth of only 5.8%, which fell notably short of the anticipated $3.35 billion. The gross margin decreased to 31.1%, below the expected 31.6%, contributing to an earnings shortfall that reflects weak performance across the core distribution segment. Additionally, management indicated potential ongoing challenges tied to the transition to a SaaS model and adverse seasonal factors impacting both revenue growth and overall earnings outlook in the near term.

Henry Schein (HSIC) has been analyzed by 25 analysts, with a consensus rating of Hold. 16% of analysts recommend a Strong Buy, 24% recommend Buy, 52% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Hold based on their latest research and market trends.

According to 25 analysts, Henry Schein (HSIC) has a Hold consensus rating as of Jul 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $76.70, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $76.70, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.